Global Carrier Screening Market 2020 By Product and Service [Service, Product, and others],By Type [Expanded Carrier Screening and Targeted Disease Carrier Screening], By Medical Condition[Pulmonary Conditions, Haematological Conditions, Neurological Conditions and Other Conditions], By Technology[DNA Sequencing, Polymerase Chain Reaction, Microarrays and Other Technologies], By End User[Hospitals, Reference Laboratories, Physician Offices & Clinics and Other]:Global Forecast to 2026 and COVID-19 Impact Outlook
Global Carrier Screening Market is valued at 1.73 USD Billion in 2019 and expected to reach USD 5.01 Billion by 2026 with the CAGR of 16.44% over the forecast period.
Scope of the report
This report analyses the global market for Carrier Screening. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Key Players
BGI Genomics, CENTOGENE, Eurofins Scientific, Fulgent Genetics, Fulgent Genetics, Gene by Gene, Illumina, Invitae, LabCorp, LabCorp,Luminex Corporation,MedGenome,Myriad Genetics,Natera Inc.,OPKO Health,Otogenetics Corporation,Pathway Genomics,Progenity,Quest Diagnostics,Sema4,Thermo Fisher Scientific,True Health and others
Above mentioned companies were scrutinized to assess competitive landscape of global Carrier Screening market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.
Review period: (2016-2026)
Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Billion
This Carrier Screening market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
Regions
• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
Market Segmentation
• Product and Service
o Service
o Product
• Type
o Expanded Carrier Screening
o Targeted Disease Carrier Screening
• Medical Condition
o Pulmonary Conditions
o Haematological Conditions
o Neurological Conditions
o Other Conditions
• Technology
o DNA Sequencing
o Polymerase Chain Reaction
o Microarrays
o Other Technologies
• End User
o Hospitals
o Reference Laboratories
o Physician Offices & Clinics
o Other
Report Coverage
• An overview of the global Carrier Screening market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Carrier Screening market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Carrier Screening market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Carrier Screening Market Report
• What is the impact of COVID 19 epidemic on the global Carrier Screening market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Carrier Screening market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Carrier Screening market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by market segment?
• How company offerings and supply chain capabilities are shifting to meet emerging market needs?
Table of Contents
1. Introduction
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
1.4. List of Abbreviations
2. Executive Summary
3. Market Overview
3.1. Market Definition
3.2. Market Scope
3.3. Market Drivers
3.4. Market Restraints
3.5. Market Opportunities and Trends
3.6. Porter’s five force analysis
3.7. SWOT Analysis
3.8. PEST Analysis
3.9. Patent Analysis
3.10. Impact of COVID 19 on Global Carrier Screening Market
4. Carrier Screening Market, By Product and Service, Market Size and Forecast 2016 -2026 (USD Billion)
4.1. Global Carrier Screening Market By Product and Service, 2016 -2026 (USD Billion)
4.1.1. Global Carrier Screening Market By Service
4.1.2. Global Carrier Screening Market By Product
4.2. Global Carrier Screening Market By Product and Service Share, 2016 -2026 (%)
5. Carrier Screening Market, By Medical Condition, Market Size and Forecast 2016 -2026 (USD Billion)
5.1. Global Carrier Screening Market By Medical Condition, 2016 -2026 (USD Billion)
5.1.1. Global Carrier Screening Market By Pulmonary Conditions
5.1.2. Global Carrier Screening Market By Hematological Conditions
5.1.3. Global Carrier Screening Market By Neurological Conditions
5.1.4. Global Carrier Screening Market By Other Conditions
5.2. Global Carrier Screening Market By Medical Condition Share, 2016 -2026 (%)
6. Carrier Screening Market, By Type, Market Size and Forecast 2016 -2026 (USD Billion)
6.1. Global Carrier Screening Market By Type, 2016 -2026 (USD Billion)
6.1.1. Global Carrier Screening Market By Expanded Carrier Screening
6.1.2. Global Carrier Screening Market By Targeted Disease Carrier Screening
6.2. Global Carrier Screening Market By Type Share, 2016 -2026 (%)
7. Carrier Screening Market, By Technology, Market Size and Forecast 2016 -2026 (USD Billion)
7.1. Global Carrier Screening Market By Technology, 2016 -2026 (USD Billion)
7.1.1. Global Carrier Screening Market By DNA Sequencing
7.1.2. Global Carrier Screening Market By Polymerase Chain Reaction
7.1.3. Global Carrier Screening Market By Microarrays
7.1.4. Global Carrier Screening Market By Other Technologies
7.2. Global Carrier Screening Market By Technology Share, 2016 -2026 (%)
8. Carrier Screening Market, By Technology, Market Size and Forecast 2016 -2026 (USD Billion)
8.1. Global Carrier Screening Market By Technology, 2016 -2026 (USD Billion)
8.1.1. Global Carrier Screening Market By Hospitals
8.1.2. Global Carrier Screening Market By Reference Laboratories
8.1.3. Global Carrier Screening Market By Physician Offices & Clinics
8.1.4. Global Carrier Screening Market By Other
8.1.5.
8.2. Global Carrier Screening Market By Technology Share, 2016 -2026 (%)
9. Carrier Screening Market, By Region Market Size and Forecast 2016 -2026
9.1. NORTH AMERICA
9.1.1. Key Findings
9.1.2. Impact of COVID 19
9.1.3. Key market trends, growth factors and opportunities
9.1.4. North America Carrier Screening Market by Country 2016 -2026 (USD Billion)
9.1.5. North America Carrier Screening Market By Product and Service 2016 -2026 (USD Billion)
9.1.6. North America Carrier Screening Market By Type 2016 -2026 (USD Billion)
9.1.7. North America Carrier Screening Market By Medical Condition 2016 -2026 (USD Billion)
9.1.8. North America Carrier Screening Market By Technology 2016 -2026 (USD Billion)
9.2. EUROPE
9.2.1. Key Findings
9.2.2. Impact of COVID 19
9.2.3. Key market trends, growth factors and opportunities
9.2.4. Europe Carrier Screening Market by Country 2016 -2026 (USD Billion)
9.2.5. Europe Carrier Screening Market By Product and Service 2016 -2026 (USD Billion)
9.2.6. Europe Carrier Screening Market By Type 2016 -2026 (USD Billion)
9.2.7. Europe Carrier Screening Market By Medical Condition 2016 -2026 (USD Billion)
9.2.8. Europe Carrier Screening Market By Technology 2016 -2026 (USD Billion)
9.3. ASIA PACIFIC
9.3.1. Key Findings
9.3.2. Impact of COVID 19
9.3.3. Key market trends, growth factors and opportunities
9.3.4. Asia Pacific Carrier Screening Market by Country 2016 -2026 (USD Billion)
9.3.5. Asia Pacific Carrier Screening Market By Product and Service 2016 -2026 (USD Billion)
9.3.6. Asia Pacific Carrier Screening Market By Type 2016 -2026 (USD Billion)
9.3.7. Asia Pacific Carrier Screening Market By Medical Condition 2016 -2026 (USD Billion)
9.3.8. Asia Pacific Carrier Screening Market By Technology 2016 -2026 (USD Billion)
9.4. LATIN AMERICA
9.4.1. Key Findings
9.4.2. Impact of COVID 19
9.4.3. Key market trends, growth factors and opportunities
9.4.4. Latin America Carrier Screening Market by Country 2016 -2026 (USD Billion)
9.4.5. Latin America Carrier Screening Market By Product and Service 2016 -2026 (USD Billion)
9.4.6. Latin America Carrier Screening Market By Type 2016 -2026 (USD Billion)
9.4.7. Latin America Carrier Screening Market By Medical Condition 2016 -2026 (USD Billion)
9.4.8. Latin America Carrier Screening Market By Technology 2016 -2026 (USD Billion)
9.5. MIDDLE EAST AND AFRICA
9.5.1. Key Findings
9.5.2. Impact of COVID 19
9.5.3. Key market trends, growth factors and opportunities
9.5.4. Middle East and Africa Carrier Screening Market by Country 2016 -2026 (USD Billion)
9.5.5. Middle East and Africa Carrier Screening Market By Product and Service 2016 -2026 (USD Billion)
9.5.6. Middle East and Africa Carrier Screening Market By Type 2016 -2026 (USD Billion)
9.5.7. Middle East and Africa Carrier Screening Market By Medical Condition 2016 -2026 (USD Billion)
9.5.8. Middle East and Africa Carrier Screening Market By Technology 2016 -2026 (USD Billion)
10. Competitive Landscape Analysis
10.1. Global Carrier Screening Market Company Revenue, (USD Billion), 2016-2019
10.2. Global Carrier Screening Market Company Share, (%), 2016-2019
11. Company Profiles
11.1. BGI Genomics
11.2. CENTOGENE
11.3. Eurofins Scientific
11.4. Fulgent Genetics
11.5. Fulgent Genetics
11.6. Gene by Gene
11.7. Illumina
11.8. Invitae
11.9. LabCorp
11.10. LabCorp
11.11. Luminex Corporation
11.12. MedGenome
11.13. Myriad Genetics
11.14. Natera Inc.
11.15. OPKO Health
11.16. company
11.17. Pathway Genomics
11.18. Progenity
11.19. Quest Diagnostics
11.20. Sema4
11.21. Thermo Fisher Scientific
11.22. True Health
11.23. Others
12. Appendix
13. List of Tables
14. List of Figures
